A detailed history of Seven Eight Capital, LP transactions in Rx Sight, Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 31,892 shares of RXST stock, worth $1.43 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
31,892
Previous 25,599 24.58%
Holding current value
$1.43 Million
Previous $1.54 Million 2.34%
% of portfolio
0.15%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.78 - $57.04 $256,628 - $358,952
6,293 Added 24.58%
31,892 $1.58 Million
Q2 2024

Aug 12, 2024

SELL
$50.42 - $64.29 $230,268 - $293,612
-4,567 Reduced 15.14%
25,599 $1.54 Million
Q1 2024

May 13, 2024

BUY
$35.51 - $57.92 $115,336 - $188,124
3,248 Added 12.07%
30,166 $1.56 Million
Q4 2023

Feb 13, 2024

BUY
$20.91 - $40.9 $562,855 - $1.1 Million
26,918 New
26,918 $1.09 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.